Insider · CIK 0001339375
Antony A Riley
Files at FBRX (Forte Biosciences, Inc.). First filing Nov 22, 2024, latest Jan 2, 2026.
Antony A Riley files SEC Form 4 as CFO at FBRX (Forte Biosciences, Inc.). Since Nov 22, 2024, Antony A Riley has reported 2 open-market buys worth $380k and 0 open-market sells worth $0, the latest filed on Jan 2, 2026.
A track record needs three past buys with six months of prices behind them; Antony A Riley has 0, so none is measured yet.
The newest scored trade: bought $255k of FBRX on Dec 30, 2025, filed Jan 2, 2026, scored 41 (moderate). In the last 12 months: 1 buy worth $255k and 0 sells worth $0.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | FBRXbuy Forte Biosciences, Inc. | $255k 9,680 shares | +30% | - | |
| 42Moderate | FBRXbuy Forte Biosciences, Inc. | $125k 22,514 shares | +273% | - |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Jun 17, 2026 |
| Apr 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +375 | - | - | 42,116 | Apr 3, 2026 |
| Apr 1, 2026 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -134 | $24.86 | $3,331 | 41,982 | Apr 3, 2026 |
| Apr 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -375 | $0.00 | $0 | 1,125 | Apr 3, 2026 |
| Jan 12, 2026 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Jan 13, 2026 |
| Jan 12, 2026 | FBRX Forte Biosciences, Inc. | AGrant or award Restricted Stock Unitsderivative | +60,000 | $0.00 | $0 | 60,000 | Jan 13, 2026 |
| Dec 30, 2025 | FBRX Forte Biosciences, Inc. | POpen-market purchase Common Stock | +9,680 | $26.33 | $255k | 41,520 | Jan 2, 2026 |
| Jan 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +375 | $0.00 | $0 | 41,895 | Jan 2, 2026 |
| Jan 1, 2026 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -154 | $27.27 | $4,200 | 41,741 | Jan 2, 2026 |
| Jan 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -375 | $0.00 | $0 | 1,500 | Jan 2, 2026 |
| Oct 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +375 | $0.00 | $0 | 31,974 | Oct 2, 2025 |
| Oct 1, 2025 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -134 | $14.52 | $1,946 | 31,840 | Oct 2, 2025 |
| Oct 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -375 | $0.00 | $0 | 1,875 | Oct 2, 2025 |
| Jul 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +375 | $0.00 | $0 | 31,733 | Jul 3, 2025 |
| Jul 1, 2025 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -134 | $12.44 | $1,667 | 31,599 | Jul 3, 2025 |
| Jul 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -375 | $0.00 | $0 | 2,250 | Jul 3, 2025 |
| Apr 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +375 | $0.00 | $0 | 31,372 | Apr 2, 2025 |
| Apr 1, 2025 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -154 | $7.43 | $1,144 | 31,218 | Apr 2, 2025 |
| Apr 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -375 | $0.00 | $0 | 2,625 | Apr 2, 2025 |
| Mar 20, 2025 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +323,000 | $0.00 | $0 | 323,000 | Mar 21, 2025 |
| Jan 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +375 | $0.00 | $0 | 31,151 | Jan 2, 2025 |
| Jan 1, 2025 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -154 | $22.71 | $3,497 | 30,997 | Jan 2, 2025 |
| Jan 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -375 | $0.00 | $0 | 3,000 | Jan 2, 2025 |
| Nov 21, 2024 | FBRX Forte Biosciences, Inc. | POpen-market purchase Common Stock | +22,514 | $5.55 | $125k | 30,776 | Nov 22, 2024 |
Questions about Antony A Riley
Answered from the filings on this page, as of the latest one.
Is Antony A Riley buying or selling?
In the last 12 months Antony A Riley reported 1 open-market buy worth $255k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $255k of FBRX on Dec 30, 2025. Grants, option exercises and tax withholding are not counted.
How did Antony A Riley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Antony A Riley has 0.
Where does Antony A Riley file Form 4?
Antony A Riley has filed Form 4 at FBRX (Forte Biosciences, Inc.) as CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.